Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »
May 15, 2010 (Vol. 30, No. 10)

N-Linked Oligosaccharide Separation

New Method Developed to Improve the Resolution of Neutral and Sialylated Glycans

  • Separation of Linkage Isomers

    Click Image To Enlarge +
    Figure 2. Separation of N-linked oligosaccharides on CarboPac PA200: (A) Effect of NaOH concentration on the separation of neutral oligosaccharides on the CarboPac PA200 column. (B) Elution of G1 before and after digestion with galactosidase. Gradient: 0–5 mM NaOAc in 50 mM NaOH from 0–40 min. Flow rate: 0.5 mL/min. (C) Profiling of N-linked oligosaccharides released from polyclonal human IgG and a mAb sample. Gradient: 1–6.5 mM NaOAc from 0–50 min, 25–130 mM NaOAc from 51–80 min. Eluting NaOH concentration: 50 mM. Flow rate: 0.35 mL/min. All separations were performed at 30°C. Peaks: 1. G0; 2. Man5; 3. G0-F; 4, 5. G1; 6. Man6; 7. G2; 8. A1; 9. A2.

    The oligosaccharide standard G1 showed two peaks, presumably the two positional isomers (Figure 1). To confirm the identities of these peaks, the G1 standard was digested with β 1,4-galactosidase and then analyzed to compare with G0 and G1.

    Results showed that, after digestion, only a minor peak appeared at the position of one of the two original G1 peaks, and a major peak eluted at the same time as the G0 standard (Figure 2B). These results show that the two original G1 peaks had terminal galactose groups and after the galactose cleavage both were converted to G0, which strongly suggests that the two original G1 peaks are the positional isomers shown in Figure 1.

    When 50 mM NaOH was used, the oxygen dip (~33 min in Chromatogram 4 in Figure 2A) interfered with the peak detection. The dip in the baseline is due to the dissolved oxygen introduced by sample injection being greater than the eluent’s oxygen concentration. The intensity of the dip is usually 1–2 nC, and can be reduced by setting a 25 µL cut volume in the sample injection command, which can reduce the amount of air injected.

    To move the dip away from the sample peaks, flow rate and sodium acetate gradient were adjusted. The oxygen dip was eluted later than the sample peaks when the flow rate was decreased from 0.5 mL/min to 0.35 mL/min, with an acetate gradient of 1–6 mM in 45 min. The good resolution of the oligosaccharide standards was maintained with this gradient.

    The optimized gradient can be extended to include elution with higher concentration of NaOAc, allowing separation of both neutral and sialylated oligosaccharides in the same injection.

    The extended gradient was used to profile the N-linked glycans released from polyclonal human IgG and a monoclonal antibody (Figure 2C). The proteins were digested with PNGase F. After 24 hours of  incubation at 37°C, the digestion mix was directly injected onto the CarboPac PA200 column and analyzed with the extended optimal gradient.

    Salts in the digestion buffer could affect the binding of the samples to the column and cause them to elute slightly earlier. Therefore, standards were dissolved in the same digestion buffer and analyzed under the same conditions. Profiling results showed that the polyclonal antibody had more neutral-type oligosaccharides than the monoclonal antibody.

    The monoclonal antibody had fewer mono-sialylated glycans, while the polyclonal human IgG had more mono-sialylated glycans than di-sialylated glycans. Comparison with the standard profile showed that the major neutral N-glycans of polyclonal human IgG were G0, G1, and G2. The two peaks labeled with an asterisk eluted later than G1 and G2 and could be G1-F and G2-F, as fucosylated oligosaccharides usually elute earlier than the same structure without the core fucose. The neutral N-glycans of the monoclonal antibody were mostly G0 and G1. In conclusion, an efficient method was developed for high-resolution separation of both neutral and sialylated N-linked oligosaccharides on the CarboPac PA200 column.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »